Neurodegenerative Disease Market is Forecast to Grow at a CAGR of 7.45% Over the Period of 2024 to 2031 | AbbVie Inc., Merck & Co. Inc., Pfizer Inc.

The Neurodegenerative Disease Market is expected to grow at a CAGR of 7.45% during the forecast period 2024-2031

Neurodegenerative Disease Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/neurodegenerative-disease-market?sz

The Neurodegenerative Disease market focuses on treatments and diagnostics for conditions like Alzheimer's, Parkinson's, and ALS, which progressively impair brain function. It includes drug therapies, gene therapies, and biomarker-based diagnostics. With rising cases and ongoing research, the market is driven by advancements in precision medicine, regenerative therapies, and AI-powered early detection solutions.

List of the Key Players in the Neurodegenerative Disease Market:

AbbVie Inc., Amneal Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC, Merck & Co. Inc., Pfizer Inc., Teva Pharmaceutical, UCB SA, Novartis, among others.

Market Dynamics:

The rising prevalence of neurodegenerative diseases is expected to drive market growth.

As people age, the risk of developing neurodegenerative diseases like Alzheimer's, Parkinson's, and delirium increases significantly. With the global population aging rapidly, the prevalence of these conditions is expected to rise, driving the growth of the neurodegenerative disease market in the coming years.

For example, according to the NIH, delirium affects between 14% and 56% of hospitalized elderly patients, impacting over 12.5 million individuals aged 65 and older each year. Additionally, data from the United Nations Department of Economic and Social Affairs highlights a sharp increase in the aging population. In 2020, there were approximately 272 million people aged 65 and above worldwide, a number projected to reach 1.5 billion by 2050. This demographic shift means that by 2050, older adults will make up over 16% of the global population, compared to 9.3% in 2020.

As a result, the rising elderly population is expected to play a major role in shaping the future of the neurodegenerative disease market, creating a growing need for effective treatments and care solutions.

Growth Forecast Projected:

The Global Neurodegenerative Disease Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Neurodegenerative Disease Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/neurodegenerative-disease-market

Segment Covered in the Neurodegenerative Disease Market:

By Indication Type: Parkinson's Disease, Amyotrophic Lateral Sclerosis, Alzheimer's Disease, Huntington Disease, Others.

By Drug Type: N-methyl-D-aspartate Receptor, Selective Serotonin Reuptake Inhibitor, the Dopamine Inhibitors, Others.

By End-User: Hospitals, Clinics, Others.

Regional Analysis for Neurodegenerative Disease Market:

The regional analysis of the Neurodegenerative Disease Market covers key regions including North America, Europe, Asia Pacific Middle East and Africa and South America. The North America with a focus on the U.S., Canada, and Mexico; Europe, highlighting major countries like the U.K., Germany, France, and Italy, along with other nations in the region; Asia-Pacific, covering India, China, Japan, South Korea, and Australia, among others; South America, with emphasis on Colombia, Brazil, and Argentina; and the Middle East & Africa, which includes Saudi Arabia, the U.A.E., South Africa, and other countries. This comprehensive regional breakdown helps identify unique market trends and growth opportunities specific to each area.

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/neurodegenerative-disease-market

People Also Ask:

➠ What is the global sales, production, consumption, import, and export value of the Neurodegenerative Disease market?

➠ Who are the leading manufacturers in the global Neurodegenerative Disease industry? What is their operational status in terms of capacity, production, sales, pricing, costs, gross margin, and revenue?

➠ What opportunities and challenges do vendors in the global Neurodegenerative Disease industry face?

➠ Which applications, end-users, or product types are expected to see growth? What is the market share for each type and application?

➠ What are the key factors and limitations affecting the growth of the Neurodegenerative Disease market?

➠ What are the various sales, marketing, and distribution channels in the global industry?

Browse More Reports: https://www.datamintelligence.com/research-report/neurodegenerative-disease-market

Global Regenerative Medicine Market: https://www.datamintelligence.com/download-sample/regenerative-medicine-market?sz

Neuromuscular Disease Therapeutics Market: https://www.datamintelligence.com/research-report/neuromuscular-disease-therapeutics-market?sz

Macular Degeneration Treatment Market: https://www.datamintelligence.com/download-sample/macular-degeneration-treatment-market?sz

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.